Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
-
CLINICAL_TRIALS study record update · 2026-04-27Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
-
CLINICAL_TRIALS study record update · 2026-04-24Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
-
CLINICAL_TRIALS study record update · 2026-04-24Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 1b/2a, MultiCenter, Open- Label Study of Pocenbrodib as Monotherapy or in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 1/2 First-Time-in-Human, Open-label, Multicenter, Dose Escalation and Expansion Study of the Oral DNA Polymerase Theta Inhibitor (POLQi) GSK4524101 and the PARP Inhibitor (PARPi) Niraparib in Adult Participants With Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-24Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples From Patients With Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members
-
CLINICAL_TRIALS study record update · 2026-04-24Phase I Trial of 5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-24A Multi-Center, Prospective, Single-Arm, Observational Study to Evaluate Real-World Outcomes for the Shape-Sensing Ion Endoluminal System
-
CLINICAL_TRIALS study record update · 2026-04-24Data Collection, Clinical Care and Interventions in CCR, NCI
-
CLINICAL_TRIALS study record update · 2026-04-24Longitudinal Sample Collection and Tracking for the Developmental Therapeutics Clinic, National Cancer Institute
-
CLINICAL_TRIALS study record update · 2026-04-24Phase I Trial of the Combination of Bortezomib and Clofarabine in Adults With Refractory Solid Tumors, Lymphomas, or Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2026-04-23Cancer Experience Registry: An Online Survey Research Study to Understand the Experiences of Cancer Patients and Caregivers
-
CLINICAL_TRIALS study record update · 2026-04-22A Phase 2, Double-blind, Placebo-Controlled Study to Evaluate LY3537021 for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Adult Participants With Malignant Disease
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase I Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Clinical Activity of RO7673396 as a Single Agent and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors Harboring RAS Mutation(s)
-
CLINICAL_TRIALS study record update · 2026-04-21Comparison of ASA, SORT, CACI, and P-POSSUM Scores for Predicting Postoperative Intensive Care Unit Requirement in Patients Undergoing Oncologic Surgery
-
CLINICAL_TRIALS study record update · 2026-04-20Retrospective Study of M7824 Related Adverse Effects in Adults With Cancer
-
CLINICAL_TRIALS study record update · 2026-04-20Extended Access of Momelotinib for Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 1, Open-Label Study to Evaluate the Safety, Biodistribution, Imaging Characteristics, and Radiation Dosimetry of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
-
CLINICAL_TRIALS study record update · 2026-04-17Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered NY-ESO-1-Specific (c259) T Cells, Alone or in Combination With Other Agents, in HLA-A2+ Participants With NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO)
-
CLINICAL_TRIALS study record update · 2026-04-14A First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-88549968, a T-cell Redirecting Bispecific Antibody for CALR-mutated Myeloproliferative Neoplasms
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
-
CLINICAL_TRIALS study record update · 2026-04-14Tissue Procurement Protocol for the Developmental Therapeutics Clinic, National Cancer Institute (NCI)
-
CLINICAL_TRIALS study record update · 2026-04-14An Open Label, Phase I Dose-finding and Expansion Study of BI 765179 as Monotherapy and in Combination With Ezabenlimab (BI 754091) in Patients With Advanced Solid Cancers, and BI 765179 in Combination With Pembrolizumab in First-line PD-L1-positive Metastatic or Incurable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)
-
CLINICAL_TRIALS study record update · 2026-04-14A Feasibility Study Investigating the Use of Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain